PATENT CLAIM ANALYSIS

Application Number: 15753976
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "04400R"]

Abstract:
The invention relates to a nucleic acid molecule for use in a method of treatment of cancer. The nucleic acid molecule comprises a sequence selected from SEQ ID NO 001 to SEQ ID NO 038. The nucleic acid molecules provided are not provided for the treatment of laryngeal cancer.

Claim (Index 4):
A pharmaceutical composition for use in a method of treatment of cancer comprising a nucleic acid molecule comprising or essentially consisting of a sequence selected from SEQ ID NO 001 to SEQ ID NO 038, provided that said cancer is not laryngeal cancer.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.67742
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13260904', '14472987', '15880032', '13919417', '13603300']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7734919928897188
- 35 USC 102 Novelty (BERT): 0.5209749927394939
- Combined Prediction Score: 0.7482402928746963
- Mean Citation Score: 283.457354
- Max Citation Score: 295.11322
- Similarity Product: 169.8915927910733

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test